| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5875745 | The American Journal of Medicine | 2015 | 11 Pages |
Abstract
The absolute risk for venous thromboembolism was low in patients with newly diagnosed rheumatoid arthritis. Initiation of a biologic DMARD seems to be associated with an increased short-term risk of hospitalization for venous thromboembolism compared with initiation of a nonbiologic DMARD or methotrexate.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Seoyoung C. MD, MSCE, ScD, Daniel H. MD, MPH, Jun MD, MPH, Jessica M. PhD, Robert J. ScD, PhD, Sebastian MD, ScD,